Anaplastic lymphoma kinase inhibitors and their effect on the kidney

Lung cancer is the leading cause of cancer-related mortality and approximately 5% of non–small-cell lung cancer (NSCLC) patients are positive for anaplastic lymphoma kinase (ALK) gene rearrangement or fusion with echinoderm microtubule-associated protein-like 4. ALK inhibitors are the mainstay treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonilla, Marco, Jhaveri, Kenar D, Izzedine, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308093/
https://www.ncbi.nlm.nih.gov/pubmed/35892021
http://dx.doi.org/10.1093/ckj/sfac062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308093/
https://www.ncbi.nlm.nih.gov/pubmed/35892021
http://dx.doi.org/10.1093/ckj/sfac062

Ejemplares similares